Tokyo Tape
Sign in
← Euglena

Annual report

2931.TEDINET S100QG7X
Period2022-01-01 → 2022-12-31
Filed2023-03-27
StandardJapan GAAP
ConsolidatedYes
Data checks21 of 22 passed
Key figures · 64
MetricValuePeriodScopeSource row
Revenue¥44.4bn2022-01-01 → 2022-12-31Cons.Net sales
Revenue¥34.4bn2020-10-01 → 2021-12-31Cons.Net sales
Operating income−¥3.5bn2022-01-01 → 2022-12-31Cons.Operating income
Operating income−¥6.6bn2020-10-01 → 2021-12-31Cons.Operating income
Ordinary income−¥2.5bn2022-01-01 → 2022-12-31Cons.Ordinary income
Ordinary income−¥6.4bn2020-10-01 → 2021-12-31Cons.Ordinary income
Profit before tax−¥2.4bn2022-01-01 → 2022-12-31Cons.Income before income taxes
Profit before tax−¥6.7bn2020-10-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)−¥2.7bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥5.0bn2020-10-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income−¥2.7bn2022-01-01 → 2022-12-31Cons.Profit loss
Net income−¥5.8bn2020-10-01 → 2021-12-31Cons.Profit loss
Total assets¥57.3bnat 2022-12-31Cons.Assets
Total assets¥61.0bnat 2021-12-31Cons.Assets
Total liabilities¥37.9bnat 2022-12-31Cons.Liabilities
Total liabilities¥40.4bnat 2021-12-31Cons.Liabilities
Net assets / equity¥19.4bnat 2022-12-31Cons.Net assets
Net assets / equity¥20.6bnat 2021-12-31Cons.Net assets
Cash and deposits¥10.0bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥9.9bnat 2021-12-31Cons.Cash and deposits
Cash & equivalents¥9.8bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥9.8bnat 2021-12-31Cons.Cash and cash equivalents
Operating cash flow¥924m2022-01-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥1.4bn2020-10-01 → 2021-12-31Cons.Net cash provided by used in operating activities
Investing cash flow¥1.2bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥10.3bn2020-10-01 → 2021-12-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥3.0bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in financing activities
Financing cash flow¥12.1bn2020-10-01 → 2021-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥-23.832022-01-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-49.072020-10-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
Net assets per share¥167.34at 2022-12-31Cons.Net assets per share (5-year summary)
Net assets per share¥181.35at 2021-12-31Cons.Net assets per share (5-year summary)
Equity ratio33.0%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio33.0%at 2021-12-31Cons.Equity to asset ratio (5-year summary)
Employees865at 2022-12-31Cons.Number of employees
Employees883at 2021-12-31Cons.Number of employees
Revenue¥6.5bn2022-01-01 → 2022-12-31StandaloneNet sales
Revenue¥9.5bn2020-10-01 → 2021-12-31StandaloneNet sales
Operating income−¥3.5bn2022-01-01 → 2022-12-31StandaloneOperating income
Operating income−¥3.4bn2020-10-01 → 2021-12-31StandaloneOperating income
Ordinary income−¥2.2bn2022-01-01 → 2022-12-31StandaloneOrdinary income
Ordinary income−¥2.6bn2020-10-01 → 2021-12-31StandaloneOrdinary income
Profit before tax−¥2.6bn2022-01-01 → 2022-12-31StandaloneIncome before income taxes
Profit before tax−¥2.7bn2020-10-01 → 2021-12-31StandaloneIncome before income taxes
Net income−¥2.7bn2022-01-01 → 2022-12-31StandaloneProfit loss
Net income−¥2.4bn2020-10-01 → 2021-12-31StandaloneProfit loss
Total assets¥26.7bnat 2022-12-31StandaloneAssets
Total assets¥27.8bnat 2021-12-31StandaloneAssets
Total liabilities¥5.2bnat 2022-12-31StandaloneLiabilities
Total liabilities¥5.5bnat 2021-12-31StandaloneLiabilities
Net assets / equity¥21.5bnat 2022-12-31StandaloneNet assets
Net assets / equity¥22.3bnat 2021-12-31StandaloneNet assets
Cash and deposits¥2.9bnat 2022-12-31StandaloneCash and deposits
Cash and deposits¥4.9bnat 2021-12-31StandaloneCash and deposits
EPS (basic)¥-23.92022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-22.942020-10-01 → 2021-12-31StandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥186.11at 2022-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥197.18at 2021-12-31StandaloneNet assets per share (5-year summary)
Equity ratio78.8%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio78.8%at 2021-12-31StandaloneEquity to asset ratio (5-year summary)
Shares issued113,105,455at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued111,161,886at 2021-12-31StandaloneTotal number of issued shares (5-year summary)
Employees250at 2022-12-31StandaloneNumber of employees
Employees212at 2021-12-31StandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 62
SegmentItemPeriodValue
Reconciling Itemsreconcilingcapex2022-01-01 → 2022-12-31¥1m
Reconciling Itemsreconcilingdepreciation2022-01-01 → 2022-12-31¥50m
Reconciling Itemsreconcilingsegment assetsat 2022-12-31¥3.4bn
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-12-31−¥1.7bn
Biofuel Businessreportable segmentcapex2022-01-01 → 2022-12-31¥22m
Biofuel Businessreportable segmentdepreciation2022-01-01 → 2022-12-31¥49m
Biofuel Businessreportable segmentemployeesat 2022-12-3143 pure
Biofuel Businessreportable segmentrevenue2022-01-01 → 2022-12-31¥262m
Biofuel Businessreportable segmentrevenue external2022-01-01 → 2022-12-31¥262m
Biofuel Businessreportable segmentsegment assetsat 2022-12-31¥947m
Biofuel Businessreportable segmentsegment profit2022-01-01 → 2022-12-31−¥789m
Health Care Businessreportable segmentcapex2022-01-01 → 2022-12-31¥406m
Health Care Businessreportable segmentdepreciation2022-01-01 → 2022-12-31¥2.2bn
Health Care Businessreportable segmentemployeesat 2022-12-31655 pure
Health Care Businessreportable segmentrevenue2022-01-01 → 2022-12-31¥41.6bn
Health Care Businessreportable segmentrevenue external2022-01-01 → 2022-12-31¥41.6bn
Health Care Businessreportable segmentsegment assetsat 2022-12-31¥49.6bn
Health Care Businessreportable segmentsegment profit2022-01-01 → 2022-12-31−¥638m
Others Businessreportable segmentcapex2022-01-01 → 2022-12-31¥48m
Others Businessreportable segmentdepreciation2022-01-01 → 2022-12-31¥34m
Others Businessreportable segmentemployeesat 2022-12-31113 pure
Others Businessreportable segmentrevenue2022-01-01 → 2022-12-31¥2.5bn
Others Businessreportable segmentrevenue external2022-01-01 → 2022-12-31¥2.5bn
Others Businessreportable segmentsegment assetsat 2022-12-31¥3.3bn
Others Businessreportable segmentsegment profit2022-01-01 → 2022-12-31−¥325m
—segment totalcapex2022-01-01 → 2022-12-31¥477m
—segment totaldepreciation2022-01-01 → 2022-12-31¥2.3bn
—segment totalrevenue2022-01-01 → 2022-12-31¥44.4bn
—segment totalrevenue external2022-01-01 → 2022-12-31¥44.4bn
—segment totalsegment assetsat 2022-12-31¥53.9bn
—segment totalsegment profit2022-01-01 → 2022-12-31−¥1.8bn
Reconciling Itemsreconcilingcapex2020-10-01 → 2021-12-31¥31m
Reconciling Itemsreconcilingdepreciation2020-10-01 → 2021-12-31¥94m
Reconciling Itemsreconcilingsegment assetsat 2021-12-31¥5.7bn
Reconciling Itemsreconcilingsegment profit2020-10-01 → 2021-12-31−¥2.2bn
Biofuel Businessreportable segmentcapex2020-10-01 → 2021-12-31¥37m
Biofuel Businessreportable segmentdepreciation2020-10-01 → 2021-12-31¥110m
Biofuel Businessreportable segmentrevenue2020-10-01 → 2021-12-31¥47m
Biofuel Businessreportable segmentrevenue external2020-10-01 → 2021-12-31¥47m
Biofuel Businessreportable segmentsegment assetsat 2021-12-31¥602m
Biofuel Businessreportable segmentsegment profit2020-10-01 → 2021-12-31−¥1.2bn
Health Care Businessreportable segmentcapex2020-10-01 → 2021-12-31¥387m
Health Care Businessreportable segmentdepreciation2020-10-01 → 2021-12-31¥1.5bn
Health Care Businessreportable segmentrevenue2020-10-01 → 2021-12-31¥33.7bn
Health Care Businessreportable segmentrevenue external2020-10-01 → 2021-12-31¥33.7bn
Health Care Businessreportable segmentsegment assetsat 2021-12-31¥52.1bn
Health Care Businessreportable segmentsegment profit2020-10-01 → 2021-12-31−¥2.8bn
Others Businessreportable segmentcapex2020-10-01 → 2021-12-31¥54m
Others Businessreportable segmentdepreciation2020-10-01 → 2021-12-31¥14m
Others Businessreportable segmentrevenue2020-10-01 → 2021-12-31¥627m
Others Businessreportable segmentrevenue external2020-10-01 → 2021-12-31¥627m
Others Businessreportable segmentsegment assetsat 2021-12-31¥2.6bn
Others Businessreportable segmentsegment profit2020-10-01 → 2021-12-31−¥373m
—segment totalcapex2020-10-01 → 2021-12-31¥479m
—segment totaldepreciation2020-10-01 → 2021-12-31¥1.6bn
—segment totalrevenue2020-10-01 → 2021-12-31¥34.4bn
—segment totalrevenue external2020-10-01 → 2021-12-31¥34.4bn
—segment totalsegment assetsat 2021-12-31¥55.3bn
—segment totalsegment profit2020-10-01 → 2021-12-31−¥4.4bn
Biofuel Businessreportable segmentemployeesat 2022-12-3143 pure
Health Care Businessreportable segmentemployeesat 2022-12-31127 pure
Others Businessreportable segmentemployeesat 2022-12-3125 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,625
ItemContextValueUnit
Legal capital surplusPrior1YearInstant_NonConsolidatedMember11602000000JPY
Legal capital surplusCurrentYearInstant_NonConsolidatedMember13316000000JPY
Capital surplusPrior1YearInstant_NonConsolidatedMember11602000000JPY
Capital surplusCurrentYearInstant_NonConsolidatedMember13316000000JPY
Retained earnings brought forwardPrior1YearInstant_NonConsolidatedMember-3542000000JPY
Retained earnings brought forwardCurrentYearInstant_NonConsolidatedMember-6222000000JPY
Retained earningsPrior1YearInstant_NonConsolidatedMember-3542000000JPY
Retained earningsCurrentYearInstant_NonConsolidatedMember-6222000000JPY
Treasury stockPrior1YearInstant_NonConsolidatedMember-34000000JPY
Treasury stockCurrentYearInstant_NonConsolidatedMember-34000000JPY
Shareholders equityPrior1YearInstant_NonConsolidatedMember21914000000JPY
Shareholders equityCurrentYearInstant_NonConsolidatedMember21044000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant_NonConsolidatedMember－JPY
Valuation difference on available for sale securitiesCurrentYearInstant_NonConsolidatedMember2000000JPY
Valuation and translation adjustmentsPrior1YearInstant_NonConsolidatedMember－JPY
Valuation and translation adjustmentsCurrentYearInstant_NonConsolidatedMember2000000JPY
Subscription rights to sharesPrior1YearInstant_NonConsolidatedMember427000000JPY
Subscription rights to sharesCurrentYearInstant_NonConsolidatedMember427000000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember22342000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember21473000000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember27794000000JPY
Liabilities and net assetsCurrentYearInstant_NonConsolidatedMember26708000000JPY
Net salesPrior1YearDuration_NonConsolidatedMember9526000000JPY
Net salesCurrentYearDuration_NonConsolidatedMember6464000000JPY
Cost of salesPrior1YearDuration_NonConsolidatedMember3390000000JPY
Cost of salesCurrentYearDuration_NonConsolidatedMember2232000000JPY
Gross profitPrior1YearDuration_NonConsolidatedMember6136000000JPY
Gross profitCurrentYearDuration_NonConsolidatedMember4232000000JPY
Selling general and administrative expensesPrior1YearDuration_NonConsolidatedMember9499000000JPY
Selling general and administrative expensesCurrentYearDuration_NonConsolidatedMember7764000000JPY
Operating incomePrior1YearDuration_NonConsolidatedMember-3362000000JPY
Operating incomeCurrentYearDuration_NonConsolidatedMember-3532000000JPY
Interest income noiPrior1YearDuration_NonConsolidatedMember542000000JPY
Interest income noiCurrentYearDuration_NonConsolidatedMember525000000JPY
Subsidy income noi bountyPrior1YearDuration_NonConsolidatedMember270000000JPY
Subsidy income noi bountyCurrentYearDuration_NonConsolidatedMember752000000JPY
Commission fee noiPrior1YearDuration_NonConsolidatedMember45000000JPY
Commission fee noiCurrentYearDuration_NonConsolidatedMember37000000JPY
Other noiPrior1YearDuration_NonConsolidatedMember59000000JPY
Other noiCurrentYearDuration_NonConsolidatedMember106000000JPY
Non operating incomePrior1YearDuration_NonConsolidatedMember918000000JPY
Non operating incomeCurrentYearDuration_NonConsolidatedMember1421000000JPY
Interest expenses noePrior1YearDuration_NonConsolidatedMember20000000JPY
Interest expenses noeCurrentYearDuration_NonConsolidatedMember9000000JPY
Stock issuance cost noePrior1YearDuration_NonConsolidatedMember160000000JPY
Stock issuance cost noeCurrentYearDuration_NonConsolidatedMember0JPY
Provision of allowance for doubtful accounts noePrior1YearDuration_NonConsolidatedMember－JPY
Provision of allowance for doubtful accounts noeCurrentYearDuration_NonConsolidatedMember78000000JPY
Other noePrior1YearDuration_NonConsolidatedMember0JPY
Other noeCurrentYearDuration_NonConsolidatedMember0JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 21 of 22 passed
balance sheet identityconsolidated 2021-12-31pass rounding
balance sheet identityconsolidated 2022-12-31pass rounding
balance sheet identitynon_consolidated 2021-12-31pass
balance sheet identitynon_consolidated 2022-12-31pass rounding
dei present pass
period resolution partial
statement vs summary · net assetsconsolidated 2021-12-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2020-10-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2020-10-01/2021-12-31pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-12-31pass
statement vs summary · revenueconsolidated 2020-10-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-01-01/2022-12-31pass
statement vs summary · revenuenon_consolidated 2020-10-01/2021-12-31pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2021-12-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2021-12-31pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass